Toddlers With Peanut Allergy Tolerate Oral Immunotherapy
(MedPage Today) -- LOUISVILLE, Ky. -- Kids under 4 years old with peanut allergies seemed to overcome their sensitivity with a treatment using peanut (Arachis hypogaea) allergen powder (PTAH, Palforzia), according to results from the POSEIDON... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 14, 2022 Category: Allergy & Immunology Source Type: news
Asthma Deterioration Slowed With Combination Inhaler
(MedPage Today) -- LOUISVILLE, Ky. -- An investigational fixed-dose combination of a short-acting beta2-adrenergic agonist and an inhaled corticosteroid appeared to slow the deterioration in lung function and reduce severe exacerbations for patients... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 14, 2022 Category: Allergy & Immunology Source Type: news
Finding Potential Ties Between Baby-Soft Skin and Risk for Food Allergy Later On
(MedPage Today) -- LOUISVILLE, Ky. -- Eczema during infancy is a known risk factor for the development of food allergies later in childhood, but what role do moisturizers play in altering that risk?
Roughly one in five infants with severe, early... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 13, 2022 Category: Allergy & Immunology Source Type: news
Sped-Up IDT an Option After Flying-Bug Stings
(MedPage Today) -- LOUISVILLE, Ky. -- An accelerated form of intradermal skin testing (IDT) was found feasible and safe in patients with suspected allergies to hymenoptera venom, such as those from bee and wasp stings, researchers stated.
In... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 13, 2022 Category: Allergy & Immunology Source Type: news
Novel Combination Inhaler for Asthma Heads to FDA Panel
(MedPage Today) -- The FDA's Pulmonary-Allergy Drugs Advisory Committee on Tuesday will consider whether a novel two-drug combination inhaler for asthma should be the first FDA-approved product containing an inhaled corticosteroid (budesonide... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 8, 2022 Category: Allergy & Immunology Source Type: news
Year in Review: COPD
(MedPage Today) -- In updated guidelines released in May, the U.S. Preventive Services Task Force (USPSTF) continued to recommend against routine screening for chronic obstructive pulmonary disease (COPD) in asymptomatic adults, and pivotal new... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 1, 2022 Category: Allergy & Immunology Source Type: news
Biologic Dupilumab Shows Sustained Benefit in Asthma Patients
(MedPage Today) -- NASHVILLE, Tenn. -- Treatment with the biologic dupilumab (Dupixent) was associated with sustained reductions in oral corticosteroid (OCS) use in asthma patients who required both low and high daily OCS doses at baseline, according... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - October 20, 2022 Category: Allergy & Immunology Source Type: news
Racial Disparities in Pulse Oximetry Persist; Sex Differences in COPD Treatment
(MedPage Today) -- NASHVILLE, Tenn. -- Racial biases persist in the use of pulse oximetry devices for patients with acute hypoxemic respiratory failure (AHRF) requiring very high levels of oxygen support, a retrospective analysis suggested.... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - October 18, 2022 Category: Allergy & Immunology Source Type: news
Allergy Meds May Make Drug Overdoses More Dangerous, CDC Says
(MedPage Today) -- Antihistamines were involved in at least 15% of recent overdose deaths, according to 2019-2020 data from 43 states and the District of Columbia.
Of 92,033 overdose deaths during this time period, 14.7% were antihistamine-positive... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - October 13, 2022 Category: Allergy & Immunology Source Type: news
Fight Cat Allergies With Newest Asthma Drug?
(MedPage Today) -- Subcutaneous immunotherapy treatment (SCIT) for reducing cat allergy symptoms appeared to be more effective and longer lasting with the help of tezepelumab (Tezspire), a monoclonal antibody recently approved for severe asthma... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - October 13, 2022 Category: Allergy & Immunology Source Type: news
Less Invasive Emphysema Treatment Matches Lung Volume Reduction Surgery
(MedPage Today) -- BARCELONA -- Eligible emphysema patients had similar levels of improvement whether treated with lung volume reduction surgery (LVRS) or bronchoscopic lung volume reduction (BLVR) with valve placement, a less-invasive option... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - September 10, 2022 Category: Allergy & Immunology Source Type: news
Are My Patients Safe Amid Rising Temps and Worsening Air Quality?
(MedPage Today) -- This summer, record-breaking temperatures have been recorded throughout Europe and continue to rise globally. At this very moment, a blistering heat wave is ripping through California. These extremes have led to heat-related... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - September 7, 2022 Category: Allergy & Immunology Source Type: news
Are Antibiotics Needed for Moderate Acute Exacerbations of COPD?
(MedPage Today) -- BARCELONA -- The need for antibiotics in patients with chronic obstructive pulmonary disease (COPD) seeking treatment for moderate acute COPD exacerbations could not be ruled out in a randomized trial from Germany, except perhaps... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - September 7, 2022 Category: Allergy & Immunology Source Type: news
Mucus Too Sticky? NAC Injections May Help
(MedPage Today) -- BARCELONA -- Patients with heavy mucus secretions that they couldn't readily expectorate obtained some relief with IV N-acetylcysteine (NAC), a researcher said here.
After 7 days of treatment in a randomized trial conducted... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - September 5, 2022 Category: Allergy & Immunology Source Type: news
Dual Bronchodilators No Help for Symptomatic Smokers With Preserved Lung Function
(MedPage Today) -- Inhaled dual bronchodilator therapy did not decrease respiratory symptoms in former or current smokers with preserved lung function, the RETHINC trial showed.
Among 535 symptomatic smokers with a 10 pack-year history and preserved... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - September 4, 2022 Category: Allergy & Immunology Source Type: news
